APO Research
Talk to an analyst

APO RESEARCH · REPORT

Estrogen and Progesterone

Compare research editions
View pricing & licenses

Selected research

Industry Research

Estrogen and Progesterone Industry Research Report 2026

19 December 2025135 pages

Choose your research edition.

Industry ResearchEstrogen and Progesterone Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Estrogen and Progesterone Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Estrogen and Progesterone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Estrogen and Progesterone Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Estrogen and Progesterone Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Estrogen and Progesterone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Estrogen and Progesterone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Estrogen and Progesterone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Estrogen and Progesterone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Estrogen and Progesterone include Aspen Pharmacare, Besins Healthcare, Dr.Kade Pharmazeutische Fabrik, F.I.S.-FABBRICA, Gedeon Richter, Jenapharm, MERCK SERONO, N.V.Organon and Novartis Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Estrogen and Progesterone market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Estrogen and Progesterone Market by Company

Aspen Pharmacare

Besins Healthcare

Dr.Kade Pharmazeutische Fabrik

F.I.S.-FABBRICA

Gedeon Richter

Jenapharm

MERCK SERONO

N.V.Organon

Novartis Pharma

Orion

Pfizer Healthcare

Teva Pharma

AstraZeneca

Bayer

Eli Lilly

Novo Nordisk

Abbott

Estrogen and Progesterone Segment by Type

Estrogen

Progesterone

Estrogen and Progesterone Segment by Application

Hospital

Pharmacy

Department of Endocrinology

Estrogen and Progesterone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estrogen and Progesterone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Estrogen and Progesterone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estrogen and Progesterone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Estrogen and Progesterone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Estrogen and Progesterone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Estrogen and Progesterone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Estrogen and Progesterone Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Estrogen and Progesterone Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Estrogen and Progesterone Sales Market Share by Manufacturers (2021-2026) Table 8. Global Estrogen and Progesterone Revenue of Manufacturers (2021-2026) Table 9. Global Estrogen and Progesterone Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Estrogen and Progesterone Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Estrogen and Progesterone Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Estrogen and Progesterone, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Estrogen and Progesterone, Product Type & Application Table 14. Global Estrogen and Progesterone Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Estrogen and Progesterone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Aspen Pharmacare Company Information Table 19. Aspen Pharmacare Business Overview Table 20. Aspen Pharmacare Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Aspen Pharmacare Estrogen and Progesterone Product Portfolio Table 22. Aspen Pharmacare Recent Developments Table 23. Besins Healthcare Company Information Table 24. Besins Healthcare Business Overview Table 25. Besins Healthcare Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Besins Healthcare Estrogen and Progesterone Product Portfolio Table 27. Besins Healthcare Recent Developments Table 28. Dr.Kade Pharmazeutische Fabrik Company Information Table 29. Dr.Kade Pharmazeutische Fabrik Business Overview Table 30. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolio Table 32. Dr.Kade Pharmazeutische Fabrik Recent Developments Table 33. F.I.S.-FABBRICA Company Information Table 34. F.I.S.-FABBRICA Business Overview Table 35. F.I.S.-FABBRICA Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolio Table 37. F.I.S.-FABBRICA Recent Developments Table 38. Gedeon Richter Company Information Table 39. Gedeon Richter Business Overview Table 40. Gedeon Richter Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Gedeon Richter Estrogen and Progesterone Product Portfolio Table 42. Gedeon Richter Recent Developments Table 43. Jenapharm Company Information Table 44. Jenapharm Business Overview Table 45. Jenapharm Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Jenapharm Estrogen and Progesterone Product Portfolio Table 47. Jenapharm Recent Developments Table 48. MERCK SERONO Company Information Table 49. MERCK SERONO Business Overview Table 50. MERCK SERONO Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. MERCK SERONO Estrogen and Progesterone Product Portfolio Table 52. MERCK SERONO Recent Developments Table 53. N.V.Organon Company Information Table 54. N.V.Organon Business Overview Table 55. N.V.Organon Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. N.V.Organon Estrogen and Progesterone Product Portfolio Table 57. N.V.Organon Recent Developments Table 58. Novartis Pharma Company Information Table 59. Novartis Pharma Business Overview Table 60. Novartis Pharma Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Novartis Pharma Estrogen and Progesterone Product Portfolio Table 62. Novartis Pharma Recent Developments Table 63. Orion Company Information Table 64. Orion Business Overview Table 65. Orion Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Orion Estrogen and Progesterone Product Portfolio Table 67. Orion Recent Developments Table 68. Pfizer Healthcare Company Information Table 69. Pfizer Healthcare Business Overview Table 70. Pfizer Healthcare Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Pfizer Healthcare Estrogen and Progesterone Product Portfolio Table 72. Pfizer Healthcare Recent Developments Table 73. Teva Pharma Company Information Table 74. Teva Pharma Business Overview Table 75. Teva Pharma Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Pharma Estrogen and Progesterone Product Portfolio Table 77. Teva Pharma Recent Developments Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. AstraZeneca Estrogen and Progesterone Product Portfolio Table 82. AstraZeneca Recent Developments Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bayer Estrogen and Progesterone Product Portfolio Table 87. Bayer Recent Developments Table 88. Eli Lilly Company Information Table 89. Eli Lilly Business Overview Table 90. Eli Lilly Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Eli Lilly Estrogen and Progesterone Product Portfolio Table 92. Eli Lilly Recent Developments Table 93. Novo Nordisk Company Information Table 94. Novo Nordisk Business Overview Table 95. Novo Nordisk Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Novo Nordisk Estrogen and Progesterone Product Portfolio Table 97. Novo Nordisk Recent Developments Table 98. Abbott Company Information Table 99. Abbott Business Overview Table 100. Abbott Estrogen and Progesterone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Abbott Estrogen and Progesterone Product Portfolio Table 102. Abbott Recent Developments Table 103. Global Estrogen and Progesterone Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Estrogen and Progesterone Sales by Region (2021-2026) & (K Units) Table 105. Global Estrogen and Progesterone Sales Market Share by Region (2021-2026) Table 106. Global Estrogen and Progesterone Sales by Region (2027-2032) & (K Units) Table 107. Global Estrogen and Progesterone Sales Market Share by Region (2027-2032) Table 108. Global Estrogen and Progesterone Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Estrogen and Progesterone Revenue Market Share by Region (2021-2026) Table 110. Global Estrogen and Progesterone Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Estrogen and Progesterone Revenue Market Share by Region (2027-2032) Table 112. North America Estrogen and Progesterone Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 114. North America Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 115. North America Estrogen and Progesterone Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Estrogen and Progesterone Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Estrogen and Progesterone Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 119. Europe Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 120. Europe Estrogen and Progesterone Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Estrogen and Progesterone Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Estrogen and Progesterone Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 124. Asia Pacific Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 125. Asia Pacific Estrogen and Progesterone Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Estrogen and Progesterone Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Estrogen and Progesterone Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 129. South America Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 130. South America Estrogen and Progesterone Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Estrogen and Progesterone Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Estrogen and Progesterone Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Estrogen and Progesterone Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Estrogen and Progesterone Sales by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Estrogen and Progesterone Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Estrogen and Progesterone Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Estrogen and Progesterone Sales by Type (2021-2026) & (K Units) Table 138. Global Estrogen and Progesterone Sales by Type (2027-2032) & (K Units) Table 139. Global Estrogen and Progesterone Sales Market Share by Type (2021-2026) Table 140. Global Estrogen and Progesterone Sales Market Share by Type (2027-2032) Table 141. Global Estrogen and Progesterone Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Estrogen and Progesterone Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Estrogen and Progesterone Revenue Market Share by Type (2021-2026) Table 144. Global Estrogen and Progesterone Revenue Market Share by Type (2027-2032) Table 145. Global Estrogen and Progesterone Price by Type (2021-2026) & (US$/Unit) Table 146. Global Estrogen and Progesterone Price by Type (2027-2032) & (US$/Unit) Table 147. Global Estrogen and Progesterone Sales by Application (2021-2026) & (K Units) Table 148. Global Estrogen and Progesterone Sales by Application (2027-2032) & (K Units) Table 149. Global Estrogen and Progesterone Sales Market Share by Application (2021-2026) Table 150. Global Estrogen and Progesterone Sales Market Share by Application (2027-2032) Table 151. Global Estrogen and Progesterone Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Estrogen and Progesterone Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Estrogen and Progesterone Revenue Market Share by Application (2021-2026) Table 154. Global Estrogen and Progesterone Revenue Market Share by Application (2027-2032) Table 155. Global Estrogen and Progesterone Price by Application (2021-2026) & (US$/Unit) Table 156. Global Estrogen and Progesterone Price by Application (2027-2032) & (US$/Unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Estrogen and Progesterone Distributors List Table 160. Estrogen and Progesterone Customers List Table 161. Estrogen and Progesterone Industry Trends Table 162. Estrogen and Progesterone Industry Drivers Table 163. Estrogen and Progesterone Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Estrogen and Progesterone Product Image Figure 5. Global Estrogen and Progesterone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Estrogen and Progesterone Market Size (2021-2032) & (US$ Million) Figure 7. Global Estrogen and Progesterone Sales (2021-2032) & (K Units) Figure 8. Global Estrogen and Progesterone Average Price (US$/Unit) & (2021-2032) Figure 9. Estrogen Product Image Figure 10. Progesterone Product Image Figure 11. Hospital Product Image Figure 12. Pharmacy Product Image Figure 13. Department of Endocrinology Product Image Figure 14. Global Estrogen and Progesterone Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Estrogen and Progesterone, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Estrogen and Progesterone Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Estrogen and Progesterone Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Estrogen and Progesterone Sales by Region in 2025 Figure 20. Global Estrogen and Progesterone Revenue by Region in 2025 Figure 21. North America Estrogen and Progesterone Market Size by Country in 2025 Figure 22. North America Estrogen and Progesterone Sales Market Share by Country (2021-2032) Figure 23. North America Estrogen and Progesterone Revenue Market Share by Country (2021-2032) Figure 24. United States Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Estrogen and Progesterone Market Size by Country in 2025 Figure 27. Europe Estrogen and Progesterone Sales Market Share by Country (2021-2032) Figure 28. Europe Estrogen and Progesterone Revenue Market Share by Country (2021-2032) Figure 29. Germany Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Nordic Countries Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Estrogen and Progesterone Market Size by Country in 2025 Figure 36. Asia Pacific Estrogen and Progesterone Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Estrogen and Progesterone Revenue Market Share by Country (2021-2032) Figure 38. China Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Estrogen and Progesterone Market Size by Country in 2025 Figure 47. South America Estrogen and Progesterone Sales Market Share by Country (2021-2032) Figure 48. South America Estrogen and Progesterone Revenue Market Share by Country (2021-2032) Figure 49. Mexico Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Colombia Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Middle East and Africa Estrogen and Progesterone Market Size by Country in 2025 Figure 54. Middle East and Africa Estrogen and Progesterone Sales Market Share by Country (2021-2032) Figure 55. Middle East and Africa Estrogen and Progesterone Revenue Market Share by Country (2021-2032) Figure 56. Turkey Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. UAE Estrogen and Progesterone Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Global Estrogen and Progesterone Sales Market Share by Type (2021-2032) Figure 60. Global Estrogen and Progesterone Revenue Market Share by Type (2021-2032) Figure 61. Global Estrogen and Progesterone Price (US$/Unit) by Type (2021-2032) Figure 62. Global Estrogen and Progesterone Sales Market Share by Application (2021-2032) Figure 63. Global Estrogen and Progesterone Revenue Market Share by Application (2021-2032) Figure 64. Global Estrogen and Progesterone Price (US$/Unit) by Application (2021-2032) Figure 65. Estrogen and Progesterone Value Chain Figure 66. Estrogen and Progesterone Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Estrogen and Progesterone Industry Opportunities and Challenges

Scope & coverage.

Types
  • Estrogen
  • Progesterone
Applications
  • Hospital
  • Pharmacy
  • Department of Endocrinology
Companies covered
  • Aspen Pharmacare
  • Besins Healthcare
  • Dr.Kade Pharmazeutische Fabrik
  • F.I.S.-FABBRICA
  • Gedeon Richter
  • Jenapharm
  • MERCK SERONO
  • N.V.Organon
  • Novartis Pharma
  • Orion
  • Pfizer Healthcare
  • Teva Pharma
  • AstraZeneca
  • Bayer
  • Eli Lilly
  • Novo Nordisk
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Estrogen and Progesterone Market Size (2021-2032)
  4. 2.2.2 Global Estrogen and Progesterone Sales (2021-2032)
  5. 2.2.3 Global Estrogen and Progesterone Market Average Price (2021-2032)
  6. 2.3 Estrogen and Progesterone by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Estrogen
  9. 2.3.3 Progesterone
  10. 2.4 Estrogen and Progesterone by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Pharmacy
  14. 2.4.4 Department of Endocrinology
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Estrogen and Progesterone Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Estrogen and Progesterone Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Estrogen and Progesterone Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Estrogen and Progesterone Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Estrogen and Progesterone Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Estrogen and Progesterone, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Estrogen and Progesterone, Product Type & Application
  8. 3.8 Global Manufacturers of Estrogen and Progesterone, Established Date
  9. 3.9 Global Estrogen and Progesterone Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Aspen Pharmacare
  2. 4.1.1 Aspen Pharmacare Company Information
  3. 4.1.2 Aspen Pharmacare Business Overview
  4. 4.1.3 Aspen Pharmacare Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Aspen Pharmacare Estrogen and Progesterone Product Portfolio
  6. 4.1.5 Aspen Pharmacare Recent Developments
  7. 4.2 Besins Healthcare
  8. 4.2.1 Besins Healthcare Company Information
  9. 4.2.2 Besins Healthcare Business Overview
  10. 4.2.3 Besins Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Besins Healthcare Estrogen and Progesterone Product Portfolio
  12. 4.2.5 Besins Healthcare Recent Developments
  13. 4.3 Dr.Kade Pharmazeutische Fabrik
  14. 4.3.1 Dr.Kade Pharmazeutische Fabrik Company Information
  15. 4.3.2 Dr.Kade Pharmazeutische Fabrik Business Overview
  16. 4.3.3 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolio
  18. 4.3.5 Dr.Kade Pharmazeutische Fabrik Recent Developments
  19. 4.4 F.I.S.-FABBRICA
  20. 4.4.1 F.I.S.-FABBRICA Company Information
  21. 4.4.2 F.I.S.-FABBRICA Business Overview
  22. 4.4.3 F.I.S.-FABBRICA Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolio
  24. 4.4.5 F.I.S.-FABBRICA Recent Developments
  25. 4.5 Gedeon Richter
  26. 4.5.1 Gedeon Richter Company Information
  27. 4.5.2 Gedeon Richter Business Overview
  28. 4.5.3 Gedeon Richter Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Gedeon Richter Estrogen and Progesterone Product Portfolio
  30. 4.5.5 Gedeon Richter Recent Developments
  31. 4.6 Jenapharm
  32. 4.6.1 Jenapharm Company Information
  33. 4.6.2 Jenapharm Business Overview
  34. 4.6.3 Jenapharm Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Jenapharm Estrogen and Progesterone Product Portfolio
  36. 4.6.5 Jenapharm Recent Developments
  37. 4.7 MERCK SERONO
  38. 4.7.1 MERCK SERONO Company Information
  39. 4.7.2 MERCK SERONO Business Overview
  40. 4.7.3 MERCK SERONO Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 MERCK SERONO Estrogen and Progesterone Product Portfolio
  42. 4.7.5 MERCK SERONO Recent Developments
  43. 4.8 N.V.Organon
  44. 4.8.1 N.V.Organon Company Information
  45. 4.8.2 N.V.Organon Business Overview
  46. 4.8.3 N.V.Organon Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 N.V.Organon Estrogen and Progesterone Product Portfolio
  48. 4.8.5 N.V.Organon Recent Developments
  49. 4.9 Novartis Pharma
  50. 4.9.1 Novartis Pharma Company Information
  51. 4.9.2 Novartis Pharma Business Overview
  52. 4.9.3 Novartis Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Novartis Pharma Estrogen and Progesterone Product Portfolio
  54. 4.9.5 Novartis Pharma Recent Developments
  55. 4.10 Orion
  56. 4.10.1 Orion Company Information
  57. 4.10.2 Orion Business Overview
  58. 4.10.3 Orion Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Orion Estrogen and Progesterone Product Portfolio
  60. 4.10.5 Orion Recent Developments
  61. 4.11 Pfizer Healthcare
  62. 4.11.1 Pfizer Healthcare Company Information
  63. 4.11.2 Pfizer Healthcare Business Overview
  64. 4.11.3 Pfizer Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Pfizer Healthcare Estrogen and Progesterone Product Portfolio
  66. 4.11.5 Pfizer Healthcare Recent Developments
  67. 4.12 Teva Pharma
  68. 4.12.1 Teva Pharma Company Information
  69. 4.12.2 Teva Pharma Business Overview
  70. 4.12.3 Teva Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Teva Pharma Estrogen and Progesterone Product Portfolio
  72. 4.12.5 Teva Pharma Recent Developments
  73. 4.13 AstraZeneca
  74. 4.13.1 AstraZeneca Company Information
  75. 4.13.2 AstraZeneca Business Overview
  76. 4.13.3 AstraZeneca Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 AstraZeneca Estrogen and Progesterone Product Portfolio
  78. 4.13.5 AstraZeneca Recent Developments
  79. 4.14 Bayer
  80. 4.14.1 Bayer Company Information
  81. 4.14.2 Bayer Business Overview
  82. 4.14.3 Bayer Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bayer Estrogen and Progesterone Product Portfolio
  84. 4.14.5 Bayer Recent Developments
  85. 4.15 Eli Lilly
  86. 4.15.1 Eli Lilly Company Information
  87. 4.15.2 Eli Lilly Business Overview
  88. 4.15.3 Eli Lilly Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Eli Lilly Estrogen and Progesterone Product Portfolio
  90. 4.15.5 Eli Lilly Recent Developments
  91. 4.16 Novo Nordisk
  92. 4.16.1 Novo Nordisk Company Information
  93. 4.16.2 Novo Nordisk Business Overview
  94. 4.16.3 Novo Nordisk Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Novo Nordisk Estrogen and Progesterone Product Portfolio
  96. 4.16.5 Novo Nordisk Recent Developments
  97. 4.17 Abbott
  98. 4.17.1 Abbott Company Information
  99. 4.17.2 Abbott Business Overview
  100. 4.17.3 Abbott Estrogen and Progesterone Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Abbott Estrogen and Progesterone Product Portfolio
  102. 4.17.5 Abbott Recent Developments
5 Global Estrogen and Progesterone Market Scenario by Region
  1. 5.1 Global Estrogen and Progesterone Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Estrogen and Progesterone Sales by Region: 2021-2032
  3. 5.2.1 Global Estrogen and Progesterone Sales by Region: 2021-2026
  4. 5.2.2 Global Estrogen and Progesterone Sales by Region: 2027-2032
  5. 5.3 Global Estrogen and Progesterone Revenue by Region: 2021-2032
  6. 5.3.1 Global Estrogen and Progesterone Revenue by Region: 2021-2026
  7. 5.3.2 Global Estrogen and Progesterone Revenue by Region: 2027-2032
  8. 5.4 North America Estrogen and Progesterone Market Facts & Figures by Country
  9. 5.4.1 North America Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Estrogen and Progesterone Sales by Country (2021-2032)
  11. 5.4.3 North America Estrogen and Progesterone Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Estrogen and Progesterone Market Facts & Figures by Country
  15. 5.5.1 Europe Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Estrogen and Progesterone Sales by Country (2021-2032)
  17. 5.5.3 Europe Estrogen and Progesterone Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.5.9 Nordic Countries
  24. 5.6 Asia Pacific Estrogen and Progesterone Market Facts & Figures by Country
  25. 5.6.1 Asia Pacific Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032
  26. 5.6.2 Asia Pacific Estrogen and Progesterone Sales by Country (2021-2032)
  27. 5.6.3 Asia Pacific Estrogen and Progesterone Revenue by Country (2021-2032)
  28. 5.6.4 China
  29. 5.6.5 Japan
  30. 5.6.6 South Korea
  31. 5.6.7 India
  32. 5.6.8 Australia
  33. 5.6.9 China Taiwan
  34. 5.6.10 Southeast Asia
  35. 5.7 South America Estrogen and Progesterone Market Facts & Figures by Country
  36. 5.7.1 South America Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032
  37. 5.7.2 South America Estrogen and Progesterone Sales by Country (2021-2032)
  38. 5.7.3 South America Estrogen and Progesterone Revenue by Country (2021-2032)
  39. 5.7.4 Mexico
  40. 5.7.5 Brazil
  41. 5.7.6 Argentina
  42. 5.7.7 Colombia
  43. 5.8 Middle East and Africa Estrogen and Progesterone Market Facts & Figures by Country
  44. 5.8.1 Middle East and Africa Estrogen and Progesterone Market Size by Country: 2021 VS 2025 VS 2032
  45. 5.8.2 Middle East and Africa Estrogen and Progesterone Sales by Country (2021-2032)
  46. 5.8.3 Middle East and Africa Estrogen and Progesterone Revenue by Country (2021-2032)
  47. 5.8.4 Turkey
  48. 5.8.5 Saudi Arabia
  49. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Estrogen and Progesterone Sales by Type (2021-2032)
  2. 6.1.1 Global Estrogen and Progesterone Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Estrogen and Progesterone Sales Market Share by Type (2021-2032)
  4. 6.2 Global Estrogen and Progesterone Revenue by Type (2021-2032)
  5. 6.2.1 Global Estrogen and Progesterone Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Estrogen and Progesterone Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Estrogen and Progesterone Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Estrogen and Progesterone Sales by Application (2021-2032)
  2. 7.1.1 Global Estrogen and Progesterone Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Estrogen and Progesterone Sales Market Share by Application (2021-2032)
  4. 7.2 Global Estrogen and Progesterone Revenue by Application (2021-2032)
  5. 7.2.1 Global Estrogen and Progesterone Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Estrogen and Progesterone Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Estrogen and Progesterone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Estrogen and Progesterone Value Chain Analysis
  2. 8.1.1 Estrogen and Progesterone Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Estrogen and Progesterone Production Mode & Process
  5. 8.2 Estrogen and Progesterone Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Estrogen and Progesterone Distributors
  8. 8.2.3 Estrogen and Progesterone Customers
9 Global Estrogen and Progesterone Analyzing Market Dynamics
  1. 9.1 Estrogen and Progesterone Industry Trends
  2. 9.2 Estrogen and Progesterone Industry Drivers
  3. 9.3 Estrogen and Progesterone Industry Opportunities and Challenges
  4. 9.4 Estrogen and Progesterone Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst